Table 2.
Databases and data sets in the BioMart of IntOGen
| Databases | Data sets | Description |
|---|---|---|
| Experiments | Gene genomic alterations | Recurrence and significance of genomic alteration (gain and loss) for each gene at the level of experiments |
| Gene transcriptomic alterations | Recurrence and significance of transcriptomic alterations (upregulation and downregulation) for each gene at the level of experiments | |
| KEGG genomic alterations | Recurrence and significance of genomic alterations (gain and loss) for each KEGG pathway at the level of experiments | |
| KEGG transcriptomic alterations | Recurrence and significance of transcriptomic alterations (upregulation and downregulation) for each KEGG pathway at the level of experiments | |
| GO genomic alterations | Recurrence and significance of genomic alterations (gain and loss) for each GO term at the level of experiments | |
| GO transcriptomic alterations | Recurrence and significance of transcriptomic alterations (upregulation and downregulation) for each GO term at the level of experiments | |
| TFBS genomic alterations | Recurrence and significance of genomic alterations (gain and loss) for putative targets of each TF at the level of experiments | |
| TFBS transcriptomic alterations | Recurrence and significance of transcriptomic alterations (upregulation and downregulation) for putative targets of each TF at the level of experiments | |
| miRNA genomic alterations | Recurrence and significance of genomic alterations (gain and loss) for putative targets of each miRNA at the level of experiments | |
| miRNA transcriptomic alterations | Recurrence and significance of transcriptomic alterations (upregulation and downregulation) for putative targets of each miRNA at the level of experiments | |
| Combinations | Gene genomic alterations | Recurrence and significance of genomic alterations (gain and loss) for each gene at the level of combinations (tumor types and subtypes) |
| Gene transcriptomic alterations | Recurrence and significance of transcriptomic alterations (upregulation and downregulation) for each gene at the level of combinations (tumor types and subtypes) | |
| KEGG genomic alterations | Recurrence and significance of genomic alterations (gain and loss) for each KEGG pathway at the level of combinations (tumor types and subtypes) | |
| KEGG transcriptomic alterations | Recurrence and significance of transcriptomic alterations (upregulation and downregulation) for each KEGG pathway at the level of combinations (tumor types and subtypes) | |
| GO genomic alterations | Recurrence and significance of genomic alterations (gain and loss) for each GO term at the level of combinations (tumor types and subtypes) | |
| GO transcriptomic alterations | Recurrence and significance of transcriptomic alterations (upregulation and downregulation) for each GO term at the level of combinations (tumor types and subtypes) | |
| TFBS genomic alterations | Recurrence and significance of genomic alterations (gain and loss) for putative targets of each TF at the level of combinations (tumor types and subtypes) | |
| TFBS transcriptomic alterations | Recurrence and significance of transcriptomic alterations (upregulation and downregulation) for putative targets of each TF at the level of combinations (tumor types and subtypes) | |
| miRNA genomic alterations | Recurrence and significance of genomic alterations (gain and loss) for putative targets of each miRNA at the level of combinations (tumor types and subtypes) | |
| miRNA transcriptomic alterations | Recurrence and significance of transcriptomic alterations (upregulation and downregulation) for putative targets of each miRNA at the level of combinations (tumor types and subtypes) | |
| Oncomodules | Combinations | Sets of genes significantly altered in each cancer type and subtype |
| Experiments | Sets of genes significantly altered in each experiment |